Richard Dean

Array ( [id] => 10016391 [patent_doc_number] => 09059414 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-16 [patent_title] => 'Phosphorescent organometallic iridium complex, light-emitting element, light-emitting device, electronic device, and lighting device' [patent_app_type] => utility [patent_app_number] => 14/539377 [patent_app_country] => US [patent_app_date] => 2014-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 35 [patent_no_of_words] => 25722 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14539377 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9813136 [patent_doc_number] => 20150025081 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-22 [patent_title] => 'NOVEL PHENYLIMIDAZOLE DERIVATIVES AS PDE10A ENZYME INHIBITORS' [patent_app_type] => utility [patent_app_number] => 14/488554 [patent_app_country] => US [patent_app_date] => 2014-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24727 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14488554 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9971371 [patent_doc_number] => 09018382 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-04-28 [patent_title] => 'Indazoles' [patent_app_type] => utility [patent_app_number] => 14/458305 [patent_app_country] => US [patent_app_date] => 2014-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 61170 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14458305 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10063851 [patent_doc_number] => 09102682 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-11 [patent_title] => 'CDK inhibitors' [patent_app_type] => utility [patent_app_number] => 14/452296 [patent_app_country] => US [patent_app_date] => 2014-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 23015 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14452296 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9958046 [patent_doc_number] => 09006251 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-04-14 [patent_title] => '4-aminoquinazolin-2-yl-1-pyrrazole-4-carboxylic acid compounds as prolyl hydroxylase inhibitors' [patent_app_type] => utility [patent_app_number] => 14/313892 [patent_app_country] => US [patent_app_date] => 2014-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46088 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 3280 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14313892 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9786357 [patent_doc_number] => 20140303177 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-09 [patent_title] => 'ORTHO-CONDENSED PYRIDINE AND PYRIMIDINE DERIVATIVES (E.G., PURINES) AS PROTEIN KINASES INHIBITORS' [patent_app_type] => utility [patent_app_number] => 14/310475 [patent_app_country] => US [patent_app_date] => 2014-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51355 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14310475 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9858499 [patent_doc_number] => 20150038516 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-05 [patent_title] => 'Inhibitors of Protein Kinases' [patent_app_type] => utility [patent_app_number] => 14/269703 [patent_app_country] => US [patent_app_date] => 2014-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 59384 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14269703 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10057251 [patent_doc_number] => 09096596 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-04 [patent_title] => 'P2X7 modulators' [patent_app_type] => utility [patent_app_number] => 14/212481 [patent_app_country] => US [patent_app_date] => 2014-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50628 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14212481 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9519101 [patent_doc_number] => 20140155593 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-05 [patent_title] => 'METHODS OF SYNTHESIS AND PURIFICATION OF HETEROARYL COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 14/174896 [patent_app_country] => US [patent_app_date] => 2014-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45917 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14174896 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9692088 [patent_doc_number] => 08822683 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-02 [patent_title] => 'CDK inhibitors' [patent_app_type] => utility [patent_app_number] => 14/162649 [patent_app_country] => US [patent_app_date] => 2014-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 22963 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14162649 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9491900 [patent_doc_number] => 20140142306 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-22 [patent_title] => 'CDK Inhibitors' [patent_app_type] => utility [patent_app_number] => 14/162637 [patent_app_country] => US [patent_app_date] => 2014-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 22935 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14162637 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9603549 [patent_doc_number] => 20140200231 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-17 [patent_title] => 'Bicyclic Pyrimidine Compounds' [patent_app_type] => utility [patent_app_number] => 14/148775 [patent_app_country] => US [patent_app_date] => 2014-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19750 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14148775 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10947229 [patent_doc_number] => 20140350248 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-27 [patent_title] => 'CHEMICAL ENTITIES AND THERAPEUTIC USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/139723 [patent_app_country] => US [patent_app_date] => 2013-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43433 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14139723 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10870531 [patent_doc_number] => 08895729 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-25 [patent_title] => 'Process for making thienopyrimidine compounds' [patent_app_type] => utility [patent_app_number] => 14/049477 [patent_app_country] => US [patent_app_date] => 2013-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12446 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14049477 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9882823 [patent_doc_number] => 08969587 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-03 [patent_title] => 'RAF kinase modulator compounds and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 14/048655 [patent_app_country] => US [patent_app_date] => 2013-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 169197 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14048655 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9212595 [patent_doc_number] => 20140011770 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-09 [patent_title] => 'COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY' [patent_app_type] => utility [patent_app_number] => 14/023158 [patent_app_country] => US [patent_app_date] => 2013-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 117736 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14023158 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9662360 [patent_doc_number] => 08809336 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-19 [patent_title] => 'Ortho-condensed pyridine and pyrimidine derivatives (e.g., purines) as protein kinases inhibitors' [patent_app_type] => utility [patent_app_number] => 14/017814 [patent_app_country] => US [patent_app_date] => 2013-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51450 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14017814 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9519093 [patent_doc_number] => 20140155585 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-05 [patent_title] => 'HAPTENS OF RISPERIDONE AND PALIPERIDONE' [patent_app_type] => utility [patent_app_number] => 13/970673 [patent_app_country] => US [patent_app_date] => 2013-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13361 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13970673 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9319334 [patent_doc_number] => 20140051672 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-20 [patent_title] => '1,4-DISUBSTITUTED PYRIDAZINE ANALOGS THERE OF AND METHODS FOR TREATING SMN-DEFICIENCY-RELATED CONDITIONS' [patent_app_type] => utility [patent_app_number] => 13/960917 [patent_app_country] => US [patent_app_date] => 2013-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 89282 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13960917 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10019555 [patent_doc_number] => 09062026 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-23 [patent_title] => 'Fused pyrimidines and substituted quinazolines as inhibitors of p97' [patent_app_type] => utility [patent_app_number] => 13/946795 [patent_app_country] => US [patent_app_date] => 2013-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37082 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 227 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13946795 [rel_patent_id] =>[rel_patent_doc_number] =>)